Oxford Nanopore Technologies plc
ONT · AIMX · Biotechnology · United Kingdom
Oxford Nanopore Technologies plc is a UK-based biotechnology company specializing in nanopore-based sequencing technology for the real-time, label-free analysis of single molecules of DNA and RNA. Founded in 2005 as a spin-out from the University of Oxford, it develops portable and high-throughput devices like the MinION (a palm-sized USB sequencer), GridION (desktop system for multiple flow cells), and PromethION (for ultra-high output), alongside automated sample preparation tools such as VolTRAX. The company's business model provides sequencers often at no upfront cost, generating revenue primarily from consumables, services, and leasing in segments like sale of goods and technical support. Its platforms enable applications in infectious diseases, human genetics, cancer research, microbiome analysis, epigenetics, outbreak surveillance, and crop science, serving life sciences, healthcare, and in vitro diagnostics. Headquartered at Oxford Science Park with around 1,315 employees, Oxford Nanopore Technologies plc plays a pivotal role in democratizing genomic analysis by making it accessible, scalable, and deployable anywhere.
Industry
Biotechnology
Healthcare sector · United Kingdom
Stories
Structural patterns identified in Oxford Nanopore Technologies plc
No stories identified yet.
Key Metrics
This company does not currently pay dividends.